By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN
Life Science Nation (LSN) is pleased to announce the confirmed investors for RESI JPM 2027, taking place in person January 11–12 at the San Francisco Marriott Marquis, with virtual partnering on January 13, 18, and 19.
As Life Science Nation’s largest conference of the year, RESI JPM connects early-stage life science companies with active investors and strategic partners during JPM Week. The event creates opportunities for targeted partnering meetings, investor panels, company presentations, and meaningful conversations that can move fundraising and partnership efforts forward.
Meet the Confirmed Investors
RESI JPM 2027 will bring together investors from across the life science ecosystem, including venture capital, corporate venture, family office, angel, and strategic investment groups. This diverse investor audience represents a broad range of therapeutic, diagnostic, medical technology, digital health, and platform technology interests.
Why Attend RESI JPM 2027?
RESI JPM gives companies a focused setting to connect directly with investors and strategic partners, present their innovations through the Innovator’s Pitch Challenge, and build relationships that can continue well beyond the conference.
With in-person programming in San Francisco and three days of virtual partnering, attendees can expand their reach, schedule targeted meetings, and make the most of JPM Week’s concentrated life science investment activity.
Whether seeking capital, strategic partnerships, licensing opportunities, or expert feedback, RESI JPM 2027 provides the connections and resources to help move your company forward.
| Register for RESI JPM 2027 |
